Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62,346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of liver metastases on clinical efficacy of first-line programmed death-1 inhibitor plus chemotherapy in esophageal squamous cell carcinoma: A post hoc analysis of ASTRUM-007 and meta-analysis.
Gao J, Song Y, Kou X, Tan Z, Zhang S, Sun M, Zhou J, Fan M, Zhang M, Song Y, Li S, Yuan Y, Zhuang W, Zhang J, Zhang L, Jiang H, Gu K, Ye H, Ke Y, Qi X, Wang Q, Zhu J, Huang J. Gao J, et al. Among authors: zhang l, zhang m, zhang s, zhang j. Cancer Med. 2024 May;13(10):e7203. doi: 10.1002/cam4.7203. Cancer Med. 2024. PMID: 38769930 Free PMC article.
First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial.
Song Y, Zhang B, Xin D, Kou X, Tan Z, Zhang S, Sun M, Zhou J, Fan M, Zhang M, Song Y, Li S, Yuan Y, Zhuang W, Zhang J, Zhang L, Jiang H, Gu K, Ye H, Ke Y, Li J, Wang Q, Zhu J, Huang J; ASTRUM-007 investigators. Song Y, et al. Among authors: zhang l, zhang m, zhang b, zhang s, zhang j. Nat Med. 2023 Feb;29(2):473-482. doi: 10.1038/s41591-022-02179-2. Epub 2023 Feb 2. Nat Med. 2023. PMID: 36732627 Free PMC article. Clinical Trial.
The efficacy and safety of anlotinib plus PD-1 inhibitor in locally advanced/metastatic esophageal squamous cell carcinoma (ESCC) patients who progressed on prior immune checkpoint inhibitors (ICIs): a retrospective real-world study (NCT 04984096).
Zhu X, Ma X, Li H, Zhang M, Cheng Y, Wu J, Yu W, Feng W, Zhao L, Li Z, Fu X, Liu J. Zhu X, et al. Among authors: zhang m. Ann Med. 2025 Dec;57(1):2443811. doi: 10.1080/07853890.2024.2443811. Epub 2024 Dec 23. Ann Med. 2025. PMID: 39711430 Free article.
Effects of carrimycin on biomarkers of inflammation and immune function in tumor patients with sepsis: A multicenter double-blind randomized controlled trial.
Nan C, Zhang X, Huang W, Zhu B, Zhao J, Lu S, Xian L, Liu K, Ma G, Yang W, Huang M, Zhou D, Zhang M, Duan Y, Wu G, Jiang Z, Zhang L, He X, Chen Y, Xing X, Wang C, Wang D, Yu K; Cancer Critical Care Medicine Committee of the Chinese Anti-Cancer Association. Nan C, et al. Among authors: zhang l, zhang m, zhang x. Pharmacol Res. 2023 Dec;198:106991. doi: 10.1016/j.phrs.2023.106991. Epub 2023 Nov 19. Pharmacol Res. 2023. PMID: 37984505 Free article. Clinical Trial.
[Outcomes of 33 patients with anaplastic large cell lymphoma treated after hematopoietic stem cell transplantation].
Lu N, Li XF, Dong YJ, Wang YN, Fu XR, Wu YM, Li YH, Wang MH, Li NN, Ren HY, Wang Z, Zhang MZ, Wu XX, Hu LD, Liu Y, Huang WR. Lu N, et al. Among authors: zhang mz. Zhonghua Xue Ye Xue Za Zhi. 2020 Feb 14;41(2):117-122. doi: 10.3760/cma.j.issn.0253-2727.2020.02.006. Zhonghua Xue Ye Xue Za Zhi. 2020. PMID: 32135627 Free PMC article. Chinese.
62,346 results
You have reached the last available page of results. Please see the User Guide for more information.